Impact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancer

Impact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancer

IntroductionThe Coronavirus Disease 2019 (COVID-19) pandemic posed critical challenges in providing care to ovarian cancer (OC) patients, including delays in OC diagnosis and treatment initiation. To accommodate for delays in OC surgery, the Society of Gynecologic Oncology (SGO) recommended preferen...

Full description

Bibliographic Details
Main Authors: Amrita Mukherjee, Natalie Shammas, Lanfang Xu, Kimberly L. Cannavale, Alec D. Gilfillan, Elizabeth A. Szamreta, Matthew Monberg, Melissa Hodeib, Chun R. Chao
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Oncology
Subjects:
COVID-19 pandemic
ovarian cancer
neoadjuvant chemotherapy
surgery
race/ethnicity
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1290719/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1290719/full

Similar Items